Stock Market Summary – September 01, 2025

1. Danish pharmaceutical firm, Novo Nordisk, saw its stock rise by approximately 3% following positive results from a “real-world” trial of its weight loss drug Wegovy. The trial results suggested that continued use of the drug led to a 57% greater reduction in the risk of heart attack, stroke, or death in individuals with obesity, cardiovascular disease, or who were overweight. However, competition remains stiff in the weight loss drug market, with rival U.S. firm Eli Lilly working on its own obesity treatments.

2. Nvidia, a favorite among retail investors for its advancements in the field of artificial intelligence (AI), experienced $867 million in net inflows over the past week. The company’s successful earnings report drove retail purchases to four times that of the day prior. In other favorites among retail investors, Palantir was the second favored stock with retail net buying over $300 million.

3. Footwear company Deckers Outdoor Corp, which manages brands including Uggs, Hoka, and Teva, has been identified as an undervalued growth stock by UBS. The shoe manufacturer has seen a year-to-date sell-off but, according to UBS analyst Jay Sole, the shares have potential to rally from $119.63 to his 12-month price target of $158. Factors driving this optimism include strong sales growth potential for their Hoka sneakers brand and the prospect of expanding into new markets such as lifestyle, apparel, and recovery.

4. Alibaba’s Hong Kong shares soared by over 19% after success in its cloud computing unit and reports on its new AI chip development. Although the tech giant’s quarterly revenue fell slightly short of projected estimates, the firm outperformed expectations with a 78% annual surge in net income. The cloud computing sector of the business was particularly successful with a 26% growth in revenue.

5. In Southeast Asia, Indonesia’s political climate saw the Jakarta Composite Index drop as much as 3.6%, impacting investor sentiment. The Indonesian rupiah also weakened against the US dollar amidst increasing living costs and protests against police violence. Experts cited the sell-off as cease of short-term nature, and expected market behaviors to stabilize as these domestic uncertainties fade.

The U.S. Court of Appeals for the Federal Circuit ruled that President Donald Trump’s imposition of tariffs was an overreach of his authority. These tariffs will be allowed to persist until Oct. 14. For August, the S&P 500 added nearly 2%, the Dow Jones Industrial Average advanced over 3%, and the Nasdaq Composite rose 1.6%. However, there may be potential volatility in markets due to the uncertainty around trade policies.

In European markets, the Stoxx Aerospace and Defense index rose 2.2%, following the U.K. government’s announcement of a £10 billion warship deal with Norway, the U.K.’s biggest ever warship export deal. Shares of BAE Systems rose 1.9%, and Babcock International saw a 2.1% increase. Danish pharmaceutical company, Novo Nordisk, saw a 1.8% increase in shares after releasing impressive trial data for its drug Wegovy.

Hong Kong-listed shares of BYD, the Chinese electric vehicle manufacturer, fell nearly 8% after reporting a 30% drop in quarterly profit due to increased price competition and frequent excessive marketing in China’s EV space. Despite the drop in profit, the company’s revenue for the second quarter grew 14% year over year, reaching about 201 billion yuan, and the half-year revenue climbed about 23% to 371.3 billion yuan, hitting a new record high in new energy vehicle sales.